Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MPV17L2 (MPV17 mitochondrial inner membrane protein like 2) is an integral protein of the mitochondrial inner membrane, playing a crucial role in the assembly and stability of mitochondrial ribosomes. It is essential for mitochondrial translation by associating with the large subunit of the mitochondrial ribosome and the monosome, thereby contributing to the biogenesis and function of mitochondrial ribosomes. Downregulation or loss of MPV17L2 impairs mitochondrial translation, leads to defective ribosome assembly, and disturbs mitochondrial DNA organization, resulting in morphological changes such as mitochondrial swelling and nucleoid aggregation. MPV17L2 is not known to function as a classical druggable target such as a receptor, enzyme, or transporter, nor is it a validated disease biomarker. Its main biological relevance lies in its fundamental role in mitochondrial gene expression and organelle stability, with rare associations to neurological diseases likely as part of mitochondrial dysfunction syndromes.
Not applicable (no known drugs or direct pharmacological modulation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MPV17 mitochondrial inner membrane protein like 2 (MPV17L2).